Guided Therapeutics (GTHP) Preferred Dividend Payments (2013 - 2026)

Guided Therapeutics has disclosed Preferred Dividend Payments across 14 years of filings, most recently posting -$1000.0 for Q2 2026.

• In Q2 2026, Preferred Dividend Payments fell 102.22% year-over-year to -$1000.0; the TTM figure through Jun 2026 stood at $576000.0 (up 244.91% YoY), while the FY2025 annual figure was $150000.0, down 13.79% from the prior year.
• Preferred Dividend Payments came in at -$1000.0 for Q2 2026 at Guided Therapeutics, down from $510000.0 in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $548000.0 in Q1 2022 to a low of -$1000.0 in Q2 2026.
• Average Preferred Dividend Payments over 5 years is $96055.6, with a median of $46000.0 recorded in 2023.
• The largest YoY upside for Preferred Dividend Payments was 1316.67% in 2026 against a maximum downside of 102.22% in 2026.
• Over 5 years, Preferred Dividend Payments stood at $50000.0 in 2022, then retreated by 2.0% to $49000.0 in 2023, then dropped by 2.04% to $48000.0 in 2024, then plunged by 50.0% to $24000.0 in 2025, then tumbled by 104.17% to -$1000.0 in 2026.
• Per Business Quant data, the three most recent Preferred Dividend Payments figures were -$1000.0 in Q2 2026, $510000.0 in Q1 2026, and $24000.0 in Q4 2025.